Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase1, Phase2, Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Truro, Moncton, Long Island City NY, Laurelton NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase3, Recruiting
Screen2Prevent (S2P)
for
HIV Infections
Location: Baltimore MD, Tampa FL, Atlanta GA, Memphis TN,
Sponsor: Westat
Sex: All
Age: 14 - 24
Code: NCT07728123
Recruiting
Transventricular Off-pump Mitral Valve Repair
for
Mitral Valve (MV) Regurgitation
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21+
Code: NCT07726173
Recruiting
A Natural History Study of RYR1-Related Disorders
for
Ryanodine Receptor 1-Related Myopathy,
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 7 - 70+
Code: NCT06287762
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Boston MA, Washington D.C. DC, Bethesda MD, Atlanta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Location: Boston MA, New York NY, East Brunswick NJ, Baltimore MD,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase2, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration